Physician profile
Ming Yang
NPI 1508065632
$20,025.63
in general payments reported to CMS, 2019-2025
6 companies · $495 in 2025
The $495 reported for 2025 was more than what 79% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $718 · 2022: $109 · 2023: $973 · 2024: $18K · 2025: $495.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Travel and Lodging: $873 · Food and Beverage: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,700.00 |
| Travel and Lodging | $872.91 |
| Food and Beverage | $625.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Imaging Healthcare North America, INC. | $17,985.00 | 2024-2025 | Umi Panorama Gs, Upmr 790 Pet, Umi550 |
| Ge Healthcare | $1,666.63 | 2019-2023 | |
| Telix Pharmaceuticals | $128.79 | 2025 | Gozellix |
| Progenics Pharmaceuticals, INC. | $108.84 | 2022 | |
| Janssen Biotech, INC. | $80.74 | 2025 | Rybrevant |
| Siemens Medical Solutions USA, INC. | $55.63 | 2023-2024 | Biograph Vision 600 (8 Ring/64 Ct), Biograph Horizon-3r |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ming Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.